P r i o r s t u d i e s have shown t h a t PA l e v e l s a r e e l e v a t e d i n blood components of CF homozygotes. We have s t u d i e d u r i n a r y PA l e v e l s and l 4 c spermidine metabolism i n c o n t r o l s and CF p a t i e n t s . The u r i n a r y PA l e v e l s in 7 CI: homozygotes were 2-10 f o l d h i g h e r than i n 8 heterozygotes and 6 normals (p<0.0001). No s t a t i s t i c a l l y s i g n i f i c a n t d i f f e r e n c e s were found between heterozygotes and c o n t r o l s . The 14c spermidine plasma decay curves i n two CF pat i e n t s with s e v e r e c l i n i c a l d i s e a s e (NIH Score <SO) were n o t s i g n i f i c a n t l y d i f f e r e n t from normal. However, u r i n a r y e x c e r t i o n > f t h e 14C r a d i o l a b e l by t h e 2 CF p a t i e n t s was only about 10% as :ompared t o 60.76% e x c r e t e d by normals a f t e r 72 hours. Urine samples were o b t a i n e d and NIH C l i n i c a l Scores were assigned t o a group o f 12 CF p a t i e n t s . Those with s c o r e s 170 (N = 4) demons t r a t e d s t a t i s t i c a l l y s i g n i f i c a n t lower l e v e l s o f p u t r e s c i n e (p c0.05) and s i g n i f i c a n t l y h i g h e r l e v e l s o f spermine (p <0.01) t h a those w i t h s c o r e s >70 (N = 8 ) . These d a t a show t h a t although plasma decay curves f o r 14c spermidine a r e s i m i l a r t o normals, t h e u r i n a r y e x c r e t i o n p a t t e r n suggests s e q u e s t r a t i o n i n CF pat i e n t s with s e v e r e c l i n i c a l d i s e a s e . F u r t h e r , polyamine l e v e l s a r e e l e v a t e d i n t h e u r i n e of CF homozygotes and appear t o c o r r el a t e w e l l w i t h t h e p a t i e n t ' s c l i n i c a l s t a t u s . ;upported by USPHS Grants CA-14783 and CA-17094 from t h e l a t i o n a l Cancer I n s t i t u t e (D.H.R.). R.B. i s an ALA Fellow.
I
P r i o r s t u d i e s have shown t h a t PA l e v e l s a r e e l e v a t e d i n blood components of CF homozygotes. We have s t u d i e d u r i n a r y PA l e v e l s and l 4 c spermidine metabolism i n c o n t r o l s and CF p a t i e n t s . The u r i n a r y PA l e v e l s in 7 CI: homozygotes were 2-10 f o l d h i g h e r than i n 8 heterozygotes and 6 normals (p<0.0001). No s t a t i s t i c a l l y s i g n i f i c a n t d i f f e r e n c e s were found between heterozygotes and c o n t r o l s . The 14c spermidine plasma decay curves i n two CF pat i e n t s with s e v e r e c l i n i c a l d i s e a s e (NIH Score <SO) were n o t s i g n i f i c a n t l y d i f f e r e n t from normal. However, u r i n a r y e x c e r t i o n > f t h e 14C r a d i o l a b e l by t h e 2 CF p a t i e n t s was only about 10% as :ompared t o 60.76% e x c r e t e d by normals a f t e r 72 hours. Urine samples were o b t a i n e d and NIH C l i n i c a l Scores were assigned t o a group o f 12 CF p a t i e n t s . Those with s c o r e s 170 (N = 4) demons t r a t e d s t a t i s t i c a l l y s i g n i f i c a n t lower l e v e l s o f p u t r e s c i n e (p c0.05) and s i g n i f i c a n t l y h i g h e r l e v e l s o f spermine (p <0.01) t h a those w i t h s c o r e s >70 (N = 8 ) . These d a t a show t h a t although plasma decay curves f o r 14c spermidine a r e s i m i l a r t o normals, t h e u r i n a r y e x c r e t i o n p a t t e r n suggests s e q u e s t r a t i o n i n CF pat i e n t s with s e v e r e c l i n i c a l d i s e a s e . F u r t h e r , polyamine l e v e l s a r e e l e v a t e d i n t h e u r i n e of CF homozygotes and appear t o c o r r el a t e w e l l w i t h t h e p a t i e n t ' s c l i n i c a l s t a t u s . ;upported by USPHS Grants CA-14783 and CA-17094 from t h e l a t i o n a l Cancer I n s t i t u t e (D.H.R.). R.B. i s an ALA Fellow.
UDIES OF H-Y ANTIGEN I N A 46,XYp-PHENOTYPIC FEMALE TH TURNER STIGMATA AND UNDIFFERENTIATED GONADS. Ror s e n f e l d , L u i g i L u z z a t t i , Raymond Hintz, O r l a n d o 7 7 M i l l e r , G l o r l a Koo, Stephen Wachtel; S t a n f o r d U n i v e r s i t y Dept of PedS, b t a n t o r d ; uepts. Hum. Gen/Uev & OBIGYN, College of Physici a n s & Surgeons, NYC; Mem. Sloan-Kettering Cancer Center, NYC.
H-Y a n t i g e n i s believed t o be t h e product of t e s t i s -d e t e r m i n i r gene(s) on the Y chromosome. A c a s e of 46,XYp-phenotypic female provided an o p p o r t u n i t y t o e v a l u a t e both s e x u a l and somatic d e e minants on the Y chromosome. At b i r t h , t h e i n f a n t had lymphedelr of t h e e x t r e m i t i e s , increased nuchal s k i n f o l d s and normal femal e x t e r n a l g e n i t a l i a . Q and C banding of p e r i p h e r a l leukocytes delr o n s t r a t e d a 46,XYp-karyotype. Laparotomy demonstrated b i l a t e r a l 1.5cm gonads with normal u t e r u s and tubes. Gonadal s e c t i o n s revealed f i b r o u s stroma w i t h f o c a l a g g r e g a t i o n s of u n d i f f e r e n t i a t e c e l l s arranged i n cords o r c l u s t e r s . At 8 y e a r s she i s a phenoty p i c female w i t h h e i g h t i n the 25th %, m u l t i p l e s t i g m a t a of Turne Syndrome and e l e v a t e d gonadotropins. H-Y phenotype assignment i s based on a b i l i t y of t e s t c e l l s t o adsorb H-Y a n t i b o d i e s fmmmous H-Y a n t i s e r a , which a r e then r e a c t e d w i t h mouse sperm. Skin f i t r b l a s t s of t h e p a t i e n t f a i l e d t o adsorb H-Y a n t i b o d i e s ; h e r p e r ip h e r a l leukocytes adsorbed c o n s i d e r a b l y l e s s than h e r f a t h e r ' s .
She was t h u s typed H -~f , a phenotype c o n s i s t e n t w i t h a d e l e t i o n model i n which a m a j o r i t y of H-Y gene copies has been l o s t . Demo n s t r a t i o n of the s t r u c t u r a l d e l e t i o n of the Y chromosome suppon t h e hypothesis t h a t l o c i e x i s t on t h e s h o r t arm of the Y which determine H-Y a n t i g e n , t e s t i c u l a r d i f f e r e n t i a t i o n of t h e p r i m i t i~ gonad and suppression of somatic s t i g m a t a of Turner Syndrome. San niego and NIClln, Rethesda, hld. S i n c e t h e r e i s no s p e c i f i c therapy f o r c y s t i n o s i s and sinccAA e c r e a s e s t h e f r e e -c y s t i n e content of c y s t i n o t i c f i h r o h l a s t s (Science 86:1040 (Science 86: , 1974 ), a randomized douhle-hlind t r i a l o f high o s e (200 mg/Kg/day) M was undertaken. An unhlinded committee o n i t o r e d t h e d a t a every 4 months. A t e n t r y t h e AA and p1;iceho i n a l l major c l i n i c a l parameters. h e r e w -r e 5 2 p a t i e n t y e a r s f o r t h e M group and 50 p a t i e n t y e a r s o r t h e PI, group. Of t h e 11 p a t i e n t s who d i e d , h e~a n c h r o n i c i a l v s i s o r were t r a n s p l a n t e d , 8 had received AA. Neither t r e a t - 
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l a s t s w h i l e n i n e o t h e r a c i d h y d r o l a s e s i n c l u d i n g neur aminidase have a c t i v i t i e s s i m i l a r t o t h o s e i n t h e c o n t r o l f i b r ob l a s t s (Biochem. Biophys. Res. Commun. 79,669,1977). E x t r a c t s of s k i n f i b r o b l a s t s from CF i n d i v i d u a l s and age, s e x , and r a c e matched c o n t r o l s were analyzed by i s o e l e c t r i c focusing on t h i n l a y e r polyacrylamide g e l s t o determine i f t h e e l e v a t e d a c t i v i t y of a-L-fucosidase i n t h e CF c e l l s r e s u l t e d from a d i f f e r e n c e i n s p e c i f c isoenzyme. F i b r o b l a s t s were seeded a t a d e n s i t y of
. O x 10 c e l l s / l 5 0 cm2 and h a r v e s t e d a f t e r 7 days w i t h t r y p s i n . C e l l p e l l e t s were suspended i n T r i t o n X-100, broken i n a Dounce homogenizer and c e n t r i f u g e d a t 10,400g f o r 20 min. The supernat a n t s o l u t i o n s were e l e c t r o f o c u s e d f o r 2 h i n an LKB Multiphor a p p a r a t u s both b e f o r e and a f t e r treatment with V i b r i o c h o l e r a e neuraminidase.
Two s e p a r a t e ampholine g r a d i e n t s , pH 3.5-10 and pH 4-7, were used. The g e l s were c u t i n 2 mm s l i c e s and a-Lf u c o s i d a s e a c t i v i t y was assayed u s i n g 4-methylumbelliferyl-a-Lfucopyranoside a s s u b s t r a t e i n c i t r a t e b u f f e r , pH 5.8.
The CF and c o n t r o l f i b r o b l a s t s had s i m i l a r isoenzyme p a t t e r n s under a l l of t h e c o n d i t i o n s d e s c r i b e d w i t h t h e exception t h a t s e v e r a l CF p r e p a r a t i o n s showed a predominance of t h e isoenzymes w i t h h i g h e r i s o e l e c t r i c p o i n t s . USPHS GM07025 and The National
Foundation-March of Dimes. I ( i n i t i a l Cr o f >1.0 2 < 3 . 5 ) P a t i e n t s r e c e i v i n g AA had a g r e a t e r mean r i s e i n serum c r e a t i n i n e (Cr) .
This was e s p e c i i l l l y t r u e i n p n t i e n t s w h o s c i n i t i a l Cr rrns >l.D & < 3 . 5 . Although small h c n i f i c i a l e f f e c t o f AA could not be excluded s t a t i s t i c a l l y , i t was more l i k e l y t h a t AA hastened t h e p r o g r e ss i o n o f r e n a l f a i l u r e . Tn view of t h i s a d v e r s e ATYP1CP.L PFESLNTATION GF TKISOKY 1 3 MOSAICISl.1 Robin S l o v e r , Eva Sujansky , P s t h u r Fohinson.
Department of Biophysics and G e n e t i c s , U n i v e r s i t y o i
Colorado Medical Center and National Jewish l : o s p i t a l , Cenver.
We have seen two u n r e l a t e d c a s e s of Trisomy 1 3 mosaicism hzitl? t h e main p r e s e n t i n g symptom of s e v e r e b i l a t e r a l deafnesc and m i c r o t i a r e s p e c t i v e l y . To o u r knowledge such a resenta at ion o f Trisomy 1 3 mosaicism h a s n o t been r e p o r t e d p r e v i o u s l y . Although t h e c l i n i c a l symptoms of Trisomy I 3 n o s a i c s arr v a r i a t l e , mental r e t a r d a t i o n and c l e f t p a l a t e a r e tt.e most frequc-ct f i n d i n g s . The f i r s t c a s e was a 1 0 y e a r o l d m e n t a l l y r e t a r d e d male with s e v e r e b i l a t e r a l d e a f n e s s , e u p l i c a t i o n of t h e u r e t e r s and a p o r t wine nevus. The second c a s e p r e s e n t e d with a r i g k t s i d e i m i c r o t i a , a h e a r t murmur and b i l a t e r a l rimiar. c r e a s e s . liic psychomotor development a t 6 m o~t t s was nom.al. Chromosome a n a l y s i s *om t h e p e r i p h e r a l l l o o l lymphocytes c u l t u r e r e v e a l e d i n both c a s e s Trisomy 1 3 i n 15% of c e l l s . Our experience i n d ic a t e s t h a t t h e d i a g n o s i s of Trisomy 1 3 nosaicism should be con- and secondary over-production of 5-oxoproline. Y -glutomy l transpeptidose (GGTP) is the primary cotobolic enzyme for GSH, and inhibition of this enzyme might thus be an appraach to correcting the consequences of GSH-S deficiency. L-serine inhibits fibroblost GGTP. Inhibition is markedly enhanced by sodium borate buffer, 20 mM serine-20 mM borate causing)95% inhibition. Serine-borate added to Eagle's MEM produced a dose and time dependent increase in GSH content of GSH-S deficient cultured fibroblasts. GSH content was doubled a t 24 hours with 40 mM erine-40 mM borate. Borote olone was without effect. Conversion of I4c -glutamic acid to 5-oxapraline by GSH-S deficient cells was decreased by 70% to near normal levels by 24-hour pre-treatment with 40 mM serine-borate. The increased cell GSH content may block overproduction of 5-oxapraline from excess Y-glutamylcysteine by feed-back inhibiting K-glutamylcysteine synthetase. Treatment produced no apparent toxicity; cell amino acid concentrations were unaffected other than a n increase in serine and phosphoserine. The study demonstrates the possible therapeutic value of on inhibitor of a major catabolic enzyme for a substrate decreased secondary to a deficiency of its synthetic enzyme.
